Center-Authored Papers

Filters: Author is Miller, Jeffrey S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Bishop MR, Alyea EP, Cairo MS, Falkenburg FJH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter DL et al..  2011.  National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(4):443-54. Abstract
Bishop MR, Alyea EP, Cairo MS, Falkenburg FJH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter D et al..  2010.  Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(5):563-4.
Brunstein CG, Petersdorf EW, Defor TE, Noreen H, Maurer D, Macmillan ML, Ustun C, Verneris MR, Miller JS, Blazar BR et al..  2015.  Impact of Allele Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
C
Cooley S, Weisdorf DJ, Guethlein LA, Klein JP, Wang T, Le CT, Marsh SGE, Geraghty DE, Spellman S, Haagenson MD et al..  2010.  Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.. Blood. 116(14):2411-9. Abstract
E
Erbe AK, Wang W, Reville PK, Carmichael L, Kim KM, Mendonca EA, Song Y, Hank JA, London WB, Naranjo A et al..  2017.  HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy.. FRONTIERS IN IMMUNOLOGY. 8 Abstract
F
Furlan SN, Watkins B, Tkachev V, Cooley S, Panoskaltsis-Mortari A, Betz K, Brown M, Hunt DJ, Schell JB, Zeleski K et al..  2016.  Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and man.. Blood. Abstract
Furlan SN, Watkins B, Tkachev V, Flynn R, Cooley S, Ramakrishnan S, Singh K, Giver C, Hamby K, Stempora L et al..  2015.  Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention.. Science translational medicine. 7(315):315ra191. Abstract
H
Hoff GA, Fischer JC, Hsu K, Cooley S, Miller JS, Wang T, Haagenson M, Spellman S, Lee SJ, Uhrberg M et al..  2016.  Recipient HLA-C Haplotypes and miRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
M
Margolin K, Morishima C, Velcheti V, Miller JS, Lee SM, Silk AW, Holtan SG, Lacroix AM, Fling SP, Kaiser JC et al..  2018.  Phase I Trial of ALT-803, a Novel Recombinant Interleukin-15 Complex, in Patients with Advanced Solid Tumors.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Miller JS, Warren EH, van den Brink MRM, Ritz J, Shlomchik WD, Murphy WJ, Barrett JA, Kolb HJ, Giralt S, Bishop MR et al..  2010.  NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: . Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(5):565-86. Abstract
Miller JS, Morishima C, McNeel DG, Patel MR, Kohrt HE, Thompson JA, Sondel PM, Wakelee HA, Disis ML, Kaiser JC et al..  2018.  A First-in-Human Phase 1 Study of Subcutaneous Outpatient Recombinant Human IL-15 (rhIL-15) in Adults with Advanced Solid Tumors.. Clinical cancer research : an official journal of the American Association for Cancer Research. 24(7):1525-1535. Abstract
O
Osborn MJ, Webber BR, Knipping F, Lonetree C-L, Tennis N, DeFeo AP, McElroy AN, Starker CG, Lee C, Gabriel R et al..  2015.  Evaluation of TCR Gene Editing achieved by TALENs, CRISPR/Cas9 and megaTAL nucleases.. Molecular therapy : the journal of the American Society of Gene Therapy. Abstract
P
Pyo C-W, Guethlein LA, Vu Q, Wang R, Abi-Rached L, Norman PJ, Marsh SGE, Miller JS, Parham P, Geraghty DE.  2010.  Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.. PloS one. 5(12):e15115. Abstract
S
Saha A, O'Connor RS, Thangavelu G, Lovitch SB, Dandamudi DB, Wilson CB, Vincent BG, Tkachev V, Pawlicki JM, Furlan SN et al..  2016.  Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality.. The Journal of clinical investigation. 126(7):2642-60. Abstract